-

Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest enhancements to the Agilent 8850 Gas Chromatograph (GC), including compatibility with single and triple quadrupole mass spectrometry (MS) systems and related tools and technologies to improve laboratory productivity. The unique design and compact size of the 8850 GC make it one of the fastest and smallest benchtop GC/MS available. It is explicitly designed for labs that require high speed and high performance in a space-saving format.

MS compatibility with the 8850 GC significantly boosts its ability to identify and quantify complex samples, making it ideal for applications in chemicals, energy, food, environmental, and forensic laboratories. MS provides detailed molecular and composition information, which is essential for accurate identification. With its high sensitivity and specificity, MS allows for precise measurement of trace substances.

To further extend the benefit of the smallest MS-connected GC available, increased temperature range, compatibility with the CTC PAL3 Series 2 Autosampler Systems, Multi-Mode Inlet (MMI), and backflush are also announced. These enabling tools expand the utility of MS for high-throughput labs and labs that analyze complex samples. This versatility greatly extends supported application areas for both research and industrial markets.

"Agilent is excited to continue the evolution of the 8850 GC by adding the power of mass spectrometry," said Mike Zhang, president of the Applied Markets Group at Agilent. "The innovations, accelerated through the Ignite Transformation, will meet or exceed the growing customer needs and further fortify Agilent as the partner of choice for the GC and GC/MS solutions."

"Combining its compact size, superior power and gas savings, and innovative design with expanded capabilities, the 8850 GC provides great benefits in a small package, helping labs meet their analytical and sustainability goals more easily," added Jim Gearing, associate vice president of marketing in the Gas Phase Division at Agilent.

The 8850 GC is engineered to deliver up to 300°C/min oven ramp rates and fast cool-down times, significantly increasing throughput and reducing turnaround times. With 45% less power usage compared to other benchtop GC systems, the 8850 GC helps analytical labs achieve their sustainability goals and save on energy costs. When combined with the 5977C, 7000E, or 7010D MS systems, the 8850 GC delivers speed, powerful instrument intelligence, and significant space and energy savings, making it an ideal choice for labs focused on high-performance analysis and environmental responsibility. Learn more by joining this live event, At Home on Any Bench: High-Performance GC/MS for Every Lab. Discover how to save space and time whilst increasing efficiency and throughput with the Agilent 8850 GC.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

MEDIA CONTACT
Naomi Goumillout
Agilent Technologies, Inc.
+1.978.314.1862
naomi.goumillout@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

MEDIA CONTACT
Naomi Goumillout
Agilent Technologies, Inc.
+1.978.314.1862
naomi.goumillout@agilent.com

More News From Agilent Technologies Inc.

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

SANTA CLARA, Calif. & SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million. Biocare is a high-growth global pathology antibody leader, serving customers with a complementary portfolio of immunohistochemistry (IHC), in sit...

Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.80 billion for the first quarter ended Jan. 31, 2026, representing growth of 7.0% reported and up 4.4% core(1) compared with the first quarter of 2025. First-quarter GAAP net income was $305 million, or $1.07 per share. This compares with $318 million, or $1.11 per share, in the first quarter of 2025. Non-GAAP(2) net income was $386 million, or $1.36 per share, during the quarter, compared wi...

Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Adam Elinoff and Head of Investor Relations Tejas Savant will participate in a fireside chat at TD Cowen’s 46th Annual Health Care Conference. The event is scheduled for 11:10 to 11:40 a.m. EST on Tuesday, March 3, 2026, in Boston, Massachusetts. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website. About Agilent Tec...
Back to Newsroom